Covid-19 antigen detection reagent has been used in anti epidemic since it was approved for marketing in China recently.
On the afternoon of March 14, song Xiaohui, deputy director of Jilin Provincial Department of industry and information technology, revealed at the press conference on covid-19 epidemic prevention and control in Jilin province that Jilin Provincial Department of industry and information technology urgently communicated with antigen reagent manufacturers such as Beijing Beijing Hotgen Biotech Co.Ltd(688068) ( Beijing Hotgen Biotech Co.Ltd(688068) . SH) and Guangzhou Guangzhou Wondfo Biotech Co.Ltd(300482) ( Guangzhou Wondfo Biotech Co.Ltd(300482) . SZ) through the National Health Commission and other channels, 12 million copies of antigen detection reagents were ordered nationwide in a short time, and 36000 copies of antigen reagents were delivered to Jilin University on the 13th.
“At 13 noon today, another 8 million people arrived.” Song Xiaohui said that in accordance with the principles of ensuring key protection, giving priority to urgent needs, overall consideration and scientific distribution, the Department of industry and information technology of Jilin Province scientifically formulated the distribution plan and planned to distribute it to key areas such as Changchun, Jilin and Yanbian, so as to speed up the speed of nucleic acid detection, and ensure the normal production of key universities and public service enterprises in other parts of the province, key enterprises The key hospitals involved in epidemic prevention and control made every effort to coordinate the delivery of the remaining 3.954 million antigen detection reagents as soon as possible.
From 0:00 to 14:00 on March 14, 144 local confirmed cases were added in Jilin Province, including 120 cases in Changchun, 18 cases in Jilin and 6 cases in Yanbian Prefecture. Nine local asymptomatic infections were added, including three in Changchun, two in Jilin, Yanbian and Meihekou.
Song Xiaohui said that the combination of nucleic acid and antigen detection is conducive to improving the detection ability, optimizing the organization and implementation, and finding out the bottom number of the epidemic situation as soon as possible.
On March 12, the State Food and Drug Administration issued a notice approving the change of covid-19 antigen product self-test application of Nanjing Nanjing Vazyme Biotech Co.Ltd(688105) , Beijing jinwofu, Shenzhen Huada Yinyuan, Guangzhou Guangzhou Wondfo Biotech Co.Ltd(300482) , and Beijing huaketai biology. Since then, five covid-19 antigen self-test products have been officially listed.
In March 13th, the State Food and Drug Administration approved 5 registration applications of New Coronavirus (2019-nCoV) antigen detection kit, namely, Beijing Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) pharmaceutical, Beijing Beijing Hotgen Biotech Co.Ltd(688068) , Tianjin Boao Seth biology, Chongqing Ming Dao Jie Biao, Beijing Le Pu diagnosis. So far, 10 covid-19 antigen detection kits have been approved for marketing.
Recently, the epidemic situation in China is frequent and complex. How to race against the virus and cut off the route of transmission is the key to epidemic prevention and control. Antigen detection is to detect the specific protein (i.e. antigen) in the virus directly. It can detect whether the human body contains the virus in the early stage of the disease, so as to provide direct evidence of virus infection. Compared with nucleic acid detection, it has the advantages of convenient operation and fast results. It is suitable for rapid screening and shunt management of people.
Relevant covid-19 antigen detection reagent enterprises are assisting in the fight against the epidemic. For example, Guangzhou Wondfo Biotech Co.Ltd(300482) in the announcement issued at 11:00 on March 13, it is the overriding task for the company to make every effort to provide emergency support for the needs of epidemic prevention and fight and provide support for epidemic prevention and control.
In March 14th, the first financial reporter learned from the 1 drug network (YI.NS) that it had reached a strategic cooperation with Bgi Genomics Co.Ltd(300676) ( Bgi Genomics Co.Ltd(300676) .SZ). The latter New Coronavirus (2019-nCoV) antigen detection kit (fluorescence immunochromatography) will be supplied nationwide through the 1 drug network digital platform, which will quickly cover the needs of the population and help the national epidemic prevention and control.
1 drug network disclosed that it will take some time for the covid-19 antigen detection kit to be purchased and put on the shelves. 1 drug network will open the product pre-sale this week. At that time, consumers can buy it in advance by entering the 1 drug network app.
In March 14th, the official website of Tianjin pharmaceutical purchasing center announced that in order to implement the notice issued by the State Council on the joint prevention and control mechanism of New Coronavirus pneumonia, it was further optimized the COVID-19 virus detection strategy, and based on nucleic acid detection, increased antigen detection was added as a supplement to COVID-19. The procurement center will carry out the centralized maintenance of New Coronavirus antigen detection reagent products on the same day. The market speculates that this may prepare for the centralized collection of covid-19 antigen detection reagents.
